ESPIRIDION ELIO: Open Payments
NPI 1235176066 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 55 payments from 10 companies in 2025. Trend: 2023 $221 · 2024 $307 · 2025 $1,249
Food & beverage: $1,249
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $265 |
| Otsuka America Pharmaceutical, Inc. | 11 | $247 |
| Neurocrine BioSciences, Inc. | 10 | $238 |
| Teva Pharmaceuticals USA, Inc. | 11 | $202 |
| Vanda Pharmaceuticals Inc. | 5 | $144 |
| Lundbeck LLC | 3 | $59 |
| ABBVIE INC. | 1 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Corium, LLC | 2 | $18 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: COBENFY, INGREZZA, UZEDY, FANAPT, REXULTI, ABILIFY ASIMTUFII, ABILIFY MAINTENA, VRAYLAR.
Industry payments across NY — which companies pay providers there.
